Latest Breaking News On - Ilead placed first in the survey conducted with 111 patient groups specializing either hepatitis or liver conditions - Page 1 : comparemela.com

In the recently published PatientView report, Gilead is ranked number one in all corporate reputation indicators by hepatitis patient groups globally Gilead also ranks first among peers in Asia by patient groups in this region HONG KONG, Sept. 15, 2022 /PRNewswire/ Gilead Sciences, Inc. ranks first among peers for overall corporate reputation, according to 300 Asian patient groups and 111 hepatitis patient groups in the 2021 PatientView Corporate Reputation of Pharma survey. This recognition is testament to Gilead's strong focus on patient centricity and deep commitment to working with patient groups to enhance the quality of care for communities across the world. "This is a remarkable achievement for Gilead and it is heartening to know that patient groups rate us highly in all areas - seeing us as the partner of choice," said Dustin Haines, Vice President & General Manager, Asia 5, Gilead Sciences. "We put patients at the heart of everything we do, and

United statesFoster cityAsia pacific rainbowDustin hainesGilead sciencesGilead sciences incView corporate reputationVice presidentGeneral managerAsia pacific rainbow grantN the recently published patientview reportIlead is ranked number one in all corporate reputation indicators by hepatitis patient groups globally gilead also ranks first among peers asia this region hong kongSept 15022 prnewswire gilead sciencesNc ranks first among peers for overall corporate reputationCcording to 300 asian patient groups and 111 hepatitis in the 2021 patientview corporate reputation of pharma survey this recognition is testament gilead 39s strong focus on centricity deep commitment working with enhance quality care for communities across world quot isa remarkable achievement it heartening know that rate us highly all areas seeing as partner choice